Have questions? Visit https://www.reddit.com/r/SNPedia

rs3732183

From SNPedia

Orientationplus
Stabilizedplus
Geno Mag Summary
(G;G) 0 common in clinvar
Make rs3732183(A;A)
Make rs3732183(A;G)
ReferenceGRCh38 38.1/141
Chromosome2
Position47466820
GeneMSH2
is asnp
is mentioned by
dbSNPrs3732183
ebirs3732183
HLIrs3732183
Exacrs3732183
Varsomers3732183
Maprs3732183
PheGenIrs3732183
hapmaprs3732183
1000 genomesrs3732183
hgdprs3732183
ensemblrs3732183
gopubmedrs3732183
geneviewrs3732183
scholarrs3732183
googlers3732183
pharmgkbrs3732183
gwascentralrs3732183
openSNPrs3732183
23andMers3732183
23andMe allrs3732183
SNP Nexus

SNPshotrs3732183
SNPdbers3732183
MSV3drs3732183
GWAS Ctlgrs3732183
GMAF0.4669
Max Magnitude0
? (A;A) (A;G) (G;G) 28

[PMID 20091185] MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy


ClinVar
Risk rs3732183(A;A)
Alt rs3732183(A;A)
Reference rs3732183(G;G)
Significance Non-pathogenic
Disease Lynch syndrome not specified Hereditary cancer-predisposing syndrome Lynch syndrome I
Variation info
Gene MSH2
CLNDBN Lynch syndrome not specified Hereditary cancer-predisposing syndrome Lynch syndrome I
Reversed 0
HGVS NC_000002.11:g.47693959G>A
CLNSRC International Society for Gastrointestinal Hereditary Tumours
CLNACC RCV000030241.3, RCV000035358.8, RCV000132147.1, RCV000144614.1,



[PMID 19930554OA-icon.png] Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.